276 related articles for article (PubMed ID: 23921231)
21. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
Saito T; Nagai M; Ladanyi M
Cancer Res; 2006 Jul; 66(14):6919-27. PubMed ID: 16849535
[TBL] [Abstract][Full Text] [Related]
22. A variant of the SYT-SSX2 fusion gene in a case of synovial sarcoma.
Otsuka S; Nishijo K; Nakayama T; Aoyama T; Ishibe T; Shibata KR; Shima Y; Nakamura T; Otsuka T; Toguchida J
Cancer Genet Cytogenet; 2006 May; 167(1):82-8. PubMed ID: 16682293
[TBL] [Abstract][Full Text] [Related]
23. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins.
dos Santos NR; de Bruijn DR; Balemans M; Janssen B; Gärtner F; Lopes JM; de Leeuw B; Geurts van Kessel A
Hum Mol Genet; 1997 Sep; 6(9):1549-58. PubMed ID: 9285793
[TBL] [Abstract][Full Text] [Related]
24. The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
Barco R; Garcia CB; Eid JE
PLoS One; 2009; 4(4):e5060. PubMed ID: 19337376
[TBL] [Abstract][Full Text] [Related]
25. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
[TBL] [Abstract][Full Text] [Related]
26. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.
van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C
Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284
[TBL] [Abstract][Full Text] [Related]
27. β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.
Barrott JJ; Illum BE; Jin H; Zhu JF; Mosbruger T; Monument MJ; Smith-Fry K; Cable MG; Wang Y; Grossmann AH; Capecchi MR; Jones KB
Oncotarget; 2015 Sep; 6(26):22758-66. PubMed ID: 26259251
[TBL] [Abstract][Full Text] [Related]
28. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital.
Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS
Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233
[TBL] [Abstract][Full Text] [Related]
29. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
Nielsen TO; Poulin NM; Ladanyi M
Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene.
Xie Y; Törnkvist M; Aalto Y; Nilsson G; Girnita L; Nagy B; Knuutila S; Larsson O
Oncogene; 2003 Oct; 22(48):7628-31. PubMed ID: 14576825
[TBL] [Abstract][Full Text] [Related]
31. Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma.
Isfort I; Berthold R; Heinst L; Wardelmann E; Larsson O; Trautmann M; Hartmann W
Mol Cancer Res; 2023 Jun; 21(6):535-547. PubMed ID: 36920288
[TBL] [Abstract][Full Text] [Related]
32. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
[TBL] [Abstract][Full Text] [Related]
33. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
[TBL] [Abstract][Full Text] [Related]
34. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
37. A novel type of SYT/SSX fusion: methodological and biological implications.
Törnkvist M; Brodin B; Bartolazzi A; Larsson O
Mod Pathol; 2002 Jun; 15(6):679-85. PubMed ID: 12065783
[TBL] [Abstract][Full Text] [Related]
38. Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression.
Brodin B; Haslam K; Yang K; Bartolazzi A; Xie Y; Starborg M; Lundeberg J; Larsson O
Gene; 2001 May; 268(1-2):173-82. PubMed ID: 11368913
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
40. SYT-SSX fusion proteins in synovial sarcomas: detection and characterization with new antibodies.
Hashimoto N; Araki N; Yoshikawa H; Myoui A; Matsumine A; Kaneko M; Sonobe H; Ochi T
Cancer Lett; 2000 Feb; 149(1-2):31-6. PubMed ID: 10737705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
